Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma

NCT03120676 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Hodgkin Lymphoma

Interventions

DRUG: Atezolizumab

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]